West Pharmaceutical Services Stock Price and Value Analysis

West Pharmaceutical Services (NYSE:WST) in our automated value investing analysis, with the cash flow history and price comparison below.

Key Facts

Advertisement helps keep Trendshare free for most readers.

Hold-time calculator

Estimate how long you need to hold West Pharmaceutical Services to reach your target.

Target type

WST Free Cash Flow Trend

Free Cash Flow trendline for WST
Free Cash Flow trendline for West Pharmaceutical Services
CSV

Based on historical returns, we believe that West Pharmaceutical Services can grow its free cash at a rate of about 7%. That's positive!

AdvantagesDisadvantages
  • This company is solid.
  • This company is making money at a decent rate.
  • This stock looks overpriced.
  • This company has a low dividend yield.
  • This company has wild ups and downs.

Inside the WST Numbers

WST Price
(West Pharmaceutical Services stock price per share)
$411.30
[?] WST Fair Price
(based on intrinsic value)
$92.92
[?] WST Safety Price (based on a variable margin of safety) $60.40
Try your own return

The fair price above uses a 10.1% discount rate, the long-run US stock return (10.1% geometric, 1926 to 2025, from Bessembinder's working paper, updated 2026-11-09), and 2.5% terminal growth. A higher rate suits a higher return target and gives a lower value.

Value per share:

[?] PE Ratio versus Sector 127% higher than other Healthcare stocks
[?] PE Ratio versus Industry 76% higher than other Medical Devices stocks
[?] Cash Yield 0.59%
[?] Free Cash Flow Jitter 37%
[?] Dividend Yield 0.21% (tax impact)
Shares Shorted 1,807,517

Insider Activity Summary

No open-market insider buys or sells are recorded for the last 12 months.

This stock has short interest! This means that people have shorted it.

Why does that matter? They've made a bet that price will decrease from where they bought it. Maybe there are financial problems, or maybe there's a value play.

As of the latest analysis, there are 1,807,517 shares shorted. With 69,134,399 shares available for purchase and an average trading volume over the past 10 trading days of 936,300, it would take at least 1.9 days for all of the short holders to cover their shorts.

Related guides: good annual rate of return · high-yield stocks · forecasting earnings growth

Free Cash Flow by Fiscal Year

Each year names the SEC filer that reported it, so a change of filer shows up here.

Fiscal yearSEC filer (CIK)Free cash flow (USD millions)
2008 105770 -3.6
2009 105770 15.9
2010 105770 33.4
2011 105770 28.2
2012 105770 79.1
2013 105770 109.6
2014 105770 70.6
2015 105770 88.0
2016 105770 80.0
2017 105770 124.0
2018 105770 158.8
2019 105770 234.5
2020 105770 331.2
2021 105770 426.1
2022 105770 535.3
2023 105770 536.3
2024 105770 363.1
2025 105770 442.2

Download the yearly data as CSV.

Price Versus Our Estimated Value

Of the 18 fiscal years we can see for West Pharmaceutical Services under its current filer, 17 show positive free cash flow.

Our fair value estimate for West Pharmaceutical Services is $92.92, below its current price of $411.30.

Free cash flow from the first three years of data averaged $15.3 million, and from the last three $447.2 million: a sharp rise.

Free cash flow is volatile from year to year, with a variability measure of 37%.

Its dividend yield is 0.21%.

These numbers change when new filings or prices arrive, so treat this page as a snapshot and check the company's own filings.

Compared With Its Sector and Industry

Its trailing P/E ratio is 127% above the average for stocks in the Healthcare sector.

Its trailing P/E ratio is 76% above the average for stocks in the Medical Devices industry.

A P/E ratio depends on trailing earnings, which one-time items can distort, so a lower P/E is not by itself evidence of value.

SEC Filer History

Every fiscal year on this page is reported by one SEC filer, CIK 105770.

Each figure on this page comes from that filer.

Risks to This Analysis

  • Free cash flow was negative in 1 of the 18 years we have.
  • Free cash flow is volatile from year to year, so the estimates depend heavily on which years are included.
  • These figures are automated calculations from SEC filings and the recent price. They may contain errors, and they do not reflect lawsuits, management changes, or other events the filings do not show.

Advertisement supports free stock analysis content.

Questions to Answer Before You Invest in WST

Does West Pharmaceutical Services have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.

Worked example: WST

This example shows how we apply the Trendshare checklist to WST: earnings power, cash generation, valuation, and margin of safety.

We check: business quality, free cash flow, P/E, and margin of safety.

  1. Step 1 — Snapshot

    • Price: 411.30
    • Market cap: $29B
    • EPS: 8.91
  2. Step 2 — Valuation checks

    • P/E: 46.162
    • FCF yield: 0.6%
    • Date checked: Nov 13, 2026
  3. Step 3 — Margin of safety

    • Compare price to fair value and safety price.
    • Look for durable cash generation and reasonable leverage.
    • Decide if it passes your personal checklist.